Faeth Therapeutics (FTH) Invested Capital (2020 - 2021)

Faeth Therapeutics (FTH) has reported Invested Capital for 2 consecutive years, with $163.7 million the latest figure, recorded in Q2 2021.

• For the quarter ending Q2 2021, Invested Capital changed N/A year-over-year to $163.7 million; the trailing twelve-month figure through Jun 2021 stood at $163.7 million (changed N/A YoY), and the FY2020 full-year result was -$55.9 million, changed N/A from the prior year.
• Invested Capital slipped to $163.7 million in Q2 2021 per FTH's latest filing, from $171.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $171.8 million in Q1 2021 and bottomed at -$55.9 million in Q4 2020.